Status: Recruiting
Refining Treatment Options for Trichomonas Vaginalis Infection: A Comparative Analysis of Metronidazole and Secnidazole
This is a multi-centered, randomized, open-label, parallel, phase IV clinical trial comparing the effectiveness and cost-effectiveness of oral multi-dose metronidazole (MTZ) and oral single-dose secnidazole (SEC) for the treatment of Trichomonas vaginalis in both women and men.
Participants needed: 1,200
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Tulane UniversityUpdated: May 6, 2026Locations: 4
Eligibility criteria
Women and men aged 18 years or older of any race/ethnicity will be included in t... [+4]
Pregnant/lactating or seeking to be pregnant [+6]